FdaApplication
NDA 218614
Identifiers
- fda_app_no: NDA218614
Properties
| Property | Value |
|---|---|
| applicant_name | IONIS PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2024-12-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRYNGOLZA (AUTOINJECTOR) | OLEZARSEN SODIUM | EQ 50MG BASE/0.8ML (EQ 50MG BASE/0.8ML) | SOLUTION;SUBCUTANEOUS |
| TRYNGOLZA (AUTOINJECTOR) | OLEZARSEN SODIUM | EQ 80MG BASE/0.8ML (EQ 80MG BASE/0.8ML) | SOLUTION;SUBCUTANEOUS |
2 products